You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2025

CLINICAL TRIALS PROFILE FOR LACTATED RINGER'S IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Lactated Ringer's In Plastic Container

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00113685 ↗ Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury Completed National Heart, Lung, and Blood Institute (NHLBI) N/A 2003-04-01 The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
NCT00113685 ↗ Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury Completed University of Washington N/A 2003-04-01 The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
NCT00181077 ↗ Hypertonic Saline Use in Preeclampsia Completed Johns Hopkins University Phase 1 2003-06-01 To compare hypertonic saline to Lactated Ringer's solution and assess whether one speeds up the process of getting rid of extra body water faster in women with preeclampsia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lactated Ringer's In Plastic Container

Condition Name

Condition Name for Lactated Ringer's In Plastic Container
Intervention Trials
Anesthesia 5
Post-ERCP Acute Pancreatitis 4
Cesarean Section 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lactated Ringer's In Plastic Container
Intervention Trials
Hypotension 16
Pancreatitis 11
Hemorrhage 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lactated Ringer's In Plastic Container

Trials by Country

Trials by Country for Lactated Ringer's In Plastic Container
Location Trials
Egypt 37
United States 33
China 12
Korea, Republic of 5
Saudi Arabia 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lactated Ringer's In Plastic Container
Location Trials
Illinois 4
California 3
Pennsylvania 3
Connecticut 3
Minnesota 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lactated Ringer's In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Lactated Ringer's In Plastic Container
Clinical Trial Phase Trials
Phase 4 39
Phase 3 14
Phase 2/Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lactated Ringer's In Plastic Container
Clinical Trial Phase Trials
Completed 64
Not yet recruiting 29
Recruiting 26
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lactated Ringer's In Plastic Container

Sponsor Name

Sponsor Name for Lactated Ringer's In Plastic Container
Sponsor Trials
Ain Shams University 9
Cairo University 6
Mansoura University 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lactated Ringer's In Plastic Container
Sponsor Trials
Other 214
Industry 17
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Lactated Ringer's Injection: Clinical Trials, Market Analysis, and Projections

Introduction to Lactated Ringer's Injection

Lactated Ringer's Injection is a sterile, nonpyrogenic solution used for fluid and electrolyte replenishment. It contains sodium chloride, sodium lactate, potassium chloride, and calcium chloride, making it an essential tool in medical settings for managing dehydration and electrolyte imbalances[1][4].

Clinical Pharmacology and Uses

Lactated Ringer's Injection serves as a source of water and electrolytes, capable of inducing diuresis depending on the patient's clinical condition. It produces a metabolic alkalinizing effect as lactate ions are metabolized into carbon dioxide and water. This solution is widely used for fluid replacement and correcting electrolyte imbalances caused by dehydration or various medical conditions[1][4].

Safety and Efficacy in Clinical Settings

The safety of Lactated Ringer's Injection has been confirmed through various tests, including USP biological tests for plastic containers and tissue culture toxicity studies. However, it is important to note that the safety and effectiveness in children have not been established by adequate and well-controlled trials[1].

Market Analysis

Current Market Size and Growth Projections

The global Lactated Ringer's Injection market is valued at USD 510.1 million in 2024 and is expected to reach USD 762.2 million by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031. This growth is driven by the rising prevalence of chronic diseases, an increasing number of surgeries worldwide, and growing healthcare expenditure[2][5].

Key Drivers of Market Growth

  • Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases is a significant driver, as these conditions often require fluid and electrolyte management.
  • Increasing Number of Surgeries: The high frequency of surgical procedures globally contributes to the demand for Lactated Ringer's Injection.
  • Growing Healthcare Expenditure: Increased spending on healthcare, particularly in developed countries, supports the market growth.
  • Awareness About Fluid Management: Growing awareness among healthcare professionals about the importance of fluid management also boosts the demand for this solution[2][5].

Market Segmentation

By Formulation

The standard lactated ringer’s solution segment is expected to contribute the highest market share, with 52.1% in 2024. This is due to its widespread acceptance and preference among medical professionals, as it closely mimics the composition of extracellular fluid and electrolytes in the blood[5].

By Volume

The 250 ml segment is expected to contribute the highest share of the market, with 48.1% in 2024. This is because the 250 ml bag is highly demanded in outpatient settings for routine surgical procedures, chemotherapy treatments, and emergency room visits[5].

Regional Market Outlook

United States

The U.S. is a leading market for Lactated Ringer's Injection due to its substantial healthcare expenditure and the high frequency of surgical procedures. Over 50 million surgical procedures are performed annually in the U.S., amplifying the demand for intravenous solutions like Lactated Ringer's Injection[5].

Asia Pacific

The Asia Pacific region exhibits the fastest growth in the Lactated Ringer's Injection market, driven by growing medical expenditures, rising instances of chronic diseases, and increasing focus of international players on expanding into emerging countries like India[5].

Regulatory Environment

The global Lactated Ringer's Injection market faces stringent regulatory norms for product approval. Manufacturers must comply with complex guidelines set by regulatory bodies such as the U.S. FDA and the European Medicines Agency (EMA). Obtaining regulatory clearance involves extensive clinical testing and documentation, making the approval process lengthy and costly[5].

Market Opportunities

Expansion of Healthcare Infrastructure in Emerging Markets

The growing healthcare infrastructure in emerging economies presents lucrative opportunities for Lactated Ringer's Injection suppliers. Countries like India, China, and Brazil are increasing healthcare spending to strengthen hospital facilities and expand medical services, generating substantial demand for intravenous fluids[5].

Impact on Stakeholders

Manufacturers

Manufacturers need to navigate the complex regulatory environment and invest in extensive clinical testing to ensure product approval. The growing demand in emerging markets offers significant opportunities for expansion.

Healthcare Providers

Healthcare providers benefit from the availability of a reliable and widely accepted solution for fluid and electrolyte management. The increasing awareness about fluid management enhances their ability to provide evidence-based care.

Patients

Patients benefit from the effective management of dehydration and electrolyte imbalances, which can significantly improve their clinical outcomes.

"Lactated Ringer’s Injection is extensively used for fluid replacement and for correcting electrolyte imbalances caused by dehydration or medical conditions."[5]

Key Takeaways

  • Market Growth: The global Lactated Ringer's Injection market is expected to grow from USD 510.1 million in 2024 to USD 762.2 million by 2031, with a CAGR of 5.9%.
  • Key Drivers: Rising prevalence of chronic diseases, increasing number of surgeries, growing healthcare expenditure, and awareness about fluid management drive the market.
  • Market Segmentation: Standard formulation and 250 ml volume segments dominate the market.
  • Regional Outlook: The U.S. and Asia Pacific region are key markets, with the latter showing the fastest growth.
  • Regulatory Environment: Stringent regulatory norms require extensive clinical testing and documentation.

FAQs

What is Lactated Ringer's Injection used for?

Lactated Ringer's Injection is used for fluid and electrolyte replenishment, correcting electrolyte imbalances, and managing dehydration.

What are the key components of Lactated Ringer's Injection?

The solution contains sodium chloride, sodium lactate, potassium chloride, and calcium chloride.

What is the projected market size of Lactated Ringer's Injection by 2031?

The global Lactated Ringer's Injection market is expected to reach USD 762.2 million by 2031.

Which region is expected to show the fastest growth in the Lactated Ringer's Injection market?

The Asia Pacific region is expected to exhibit the fastest growth due to growing medical expenditures and rising instances of chronic diseases.

What are the main drivers of the Lactated Ringer's Injection market growth?

The main drivers include the rising prevalence of chronic diseases, increasing number of surgeries, growing healthcare expenditure, and increasing awareness about fluid management.

Sources

  1. Baxter Canada. Lactated Ringer's Injection, USP. November 19, 2018.
  2. Coherent Market Insights. Lactated Ringers Injection Market Size and Trends.
  3. Cognitive Market Research. Lactated Ringer Injection Market Report 2024 (Global Edition).
  4. FDA. Lactated Ringer's and 5% Dextrose Injection, USP.
  5. Coherent Market Insights. Lactated Ringers Injection Market - Report, Trends, Share & Insights.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.